New samarium(III), gadolinium(III), and dysprosium(III) complexes of coumarin-3-carboxylic acid as antiproliferative agents

Metal-Based Drugs

Volumn 2007, Issue , 2007, Pages

  Kostova, Irena ^a   Momekov, Georgi ^a   Stancheva, Peya ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947121652     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/15925     Document Type: Article

References (32)

1. D. Egan R. O'Kennedy E. Moran D. Cox E. Prosser R. D. Thornes The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metabolism Reviews 22 5 1990 503 529
2. J. R. S. Hoult M. Payá Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. General Pharmacology 27 4 1996 713 722
3. P. Laurin D. Ferroud M. Klich Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B. Bioorganic and Medicinal Chemistry Letters 9 14 1999 2079 2084
4. A. Matsumoto P. C. Hanawalt Histone H3 and heat shock protein GRP78 are selectively cross-linked to DNA by photoactivated gilvocarcin V in human fibroblasts. Cancer Research 60 14 2000 3921 3926
5. V. P. Kelly E. M. Ellis M. M. Manson Chemoprevention of aflatoxin B 1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B 1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H: quinone oxidoreductase in rat liver. Cancer Research 60 4 2000 957 969
6. S. Kirkiacharian serge.kirkiacharian@cep.u-psud.fr D. T. Thuy S. Sicsic R. Bakhchinian R. Kurkjian T. Tonnaire Structure-activity relationships of some 3-substituted-4-hydroxycoumarins as HIV-1 protease inhibitors. Il Farmaco 57 9 2002 703 708
7. D. Yu M. Suzuki L. Xie S. L. Morris-Natschke K.-H. Lee khlee@email.unc.edu Recent progress in the development of coumarin derivatives as potent anti-HIV agents. Medicinal Research Reviews 23 3 2003 322 345
8. E. M. Marshall M. Ryles K. Butler L. Weiss Treatment of advanced renal cell carcinoma (RCC) with coumarin and cimetidine: longterm follow-up of patients treated on a phase I trial. Journal of Cancer Research and Clinical Oncology 120 1994 535 538
9. D. Conley E. M. Marshall Effects of coumarin on human tumour cell growth and cell cycle analysis in vitro. Proceedings of the American Association for Cancer Research 28 1987 63
10. R. D. Thornes L. Daly G. Lynch Treatment with coumarin to prevent or delay recurrence of malignant melanoma. Journal of Cancer Research and Clinical Oncology 120, supplement 1 1994 S32 S34
11. M. E. Marshall J. L. Mohler K. Edmonds An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin. Journal of Cancer Research and Clinical Oncology 120, supplement 1 1994 S39 S42
12. J. L. Mohler B. T. Williams I. M. Thompson M. E. Marshall Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinoma. Journal of Cancer Research and Clinical Oncology 120, supplement 1 1994 S35 S38
13. E. von Angerer M. Kager A. Maucher Antitumour activity of coumarin in prostate and mammary cancer models. Journal of Cancer Research and Clinical Oncology 120, supplement 1 1994 S14 S16
14. B. G. Lake Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. Food and Chemical Toxicology 37 4 1999 423 453
15. M. E. Marshall K. Butler A. Fried Phase I evaluation of coumarin (1,2-benzopyrone) and cimetidine in patients with advanced malignancies. Molecular Biotherapy 3 3 1991 170 178
16. M. E. Marshall K. Kervin C. Benefield Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitro. Journal of Cancer Research and Clinical Oncology 120, supplement 1 1994 S3 S10
17. R. B. Myers M. Parker W. E. Grizzle The effects of coumarin and suramin on the growth of malignant renal and prostatic cell lines. Journal of Cancer Research and Clinical Oncology 120, supplement 1 1994 S11 S13
18. S. Kawaii Y. Tomono K. Ogawa M. Sugiura M. Yano Y. Yoshizawa The antiproliferative effect of coumarins on several cancer cell lines. Anticancer Research 21 2A 2001 917 923
19. I. Kostova I. Manolov I. Nicolova S. Konstantinov M. Karaivanova New lanthanide complexes of 4-methyl-7-hydroxycoumarin and their pharmacological activity. European Journal of Medicinal Chemistry 36 4 2001 339 347
20. I. Kostova I. Manolov S. Konstantinov M. Karaivanova Synthesis, physicochemical characterisation and cytotoxic screening of new complexes of cerium, lanthanum and neodymium with Warfarin and Coumachlor sodium salts. European Journal of Medicinal Chemistry 34 1 1999 63 68
21. I. Manolov I. Kostova S. Konstantinov M. Karaivanova Synthesis, physicochemical characterization and cytotoxic screening of new complexes of cerium, lanthanum and neodymium with Niffcoumar sodium salt. European Journal of Medicinal Chemistry 34 10 1999 853 858
22. I. Manolov I. Kostova T. Netzeva S. Konstantinov M. Karaivanova Cytotoxic activity of cerium complexes with coumarin derivatives. Molecular modeling of the ligands. Archiv der Pharmazie: Pharmaceutical and Medicinal Chemistry 333 4 2000 93 98
23. I. Kostova I. Manolov I. Nicolova mira@satline.net N. D. Danchev New metal complexes of 4-methyl-7-hydroxycoumarin sodium salt and their pharmacological activity. Il Farmaco 56 9 2001 707 713
24. I. Kostova I. Manolov M. Karaivanova Synthesis, physicochemical characterization, and cytotoxic screening of new zirconium complexes with coumarin derivatives. Archiv der Pharmazie: Pharmaceutical and Medicinal Chemistry 334 5 2001 157 162
25. I. Kostova irenakostova@yahoo.com I. Manolov G. Momekov Cytotoxic activity of new neodymium (III) complexes of bis-coumarins. European Journal of Medicinal Chemistry 39 9 2004 765 775
26. I. Kostova irenakostova@yahoo.com N. Trendafilova G. Momekov Theoretical and spectroscopic evidence for coordination ability of 3,3′-benzylidenedi- 4-hydroxycoumarin. New neodymium (III) complex and its cytotoxic effect. Journal of Inorganic Biochemistry 99 2 2005 477 487
27. I. Kostova irenakostova@yahoo.com G. Momekov M. Zaharieva M. Karaivanova Cytotoxic activity of new lanthanum (III) complexes of bis-coumarins. European Journal of Medicinal Chemistry 40 6 2005 542 551
28. I. Kostova irenakostova@yahoo.com N. Trendafilova T. Mihaylov Theoretical and spectroscopic studies of pyridyl substituted bis-coumarins and their new neodymium (III) complexes. Chemical Physics 314 1-3 2005 73 84
29. I. Kostova irenakostova@yahoo.com I. Manolov G. Momekov T. Tzanova S. Konstantinov M. Karaivanova Cytotoxic activity of new cerium (III) complexes of bis-coumarins. European Journal of Medicinal Chemistry 40 12 2005 1246 1254
30. H. G. Drexler R. A. F. MacLeod C. C. Uphoff Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia. Leukemia Research 23 3 1999 207 215
31. Tz. Mihaylov N. Trendafilova ntrend@svr.igic.bas.bg I. Kostova I. Georgieva G. Bauer DFT modeling and spectroscopic study of metal-ligand bonding in La(III) complex of coumarin-3-carboxylic acid. Chemical Physics 327 2-3 2006 209 219
32. I. Georgieva N. Trendafilova W. Kiefer V. K. Rastogi I. Kostova Vibrational and theoretical study of coumarin-3-carboxylic acid binding mode in Ce(III) and Nd(III) complexes. to appear in Vibrational Spectroscopy